Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Health Catalyst Inc (NASDAQ: HCAT) closed at $3.66 up 2.23% from its previous closing price of $3.58. In other words, the price has increased by $2.23 from its previous closing price. On the day, 0.57 million shares were traded. HCAT stock price reached its highest trading level at $3.81 during the session, while it also had its lowest trading level at $3.6.
Ratios:
For a deeper understanding of Health Catalyst Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 1.42. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 0.46.
On January 08, 2025, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $9.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 03 ’25 when LeSueur Daniel sold 5,209 shares for $4.15 per share. The transaction valued at 21,604 led to the insider holds 211,041 shares of the business.
DANIEL LESUEUR bought 10,418 shares of HCAT for $46,360 on Apr 03 ’25. On Mar 06 ’25, another insider, Landry Benjamin, who serves as the General Counsel of the company, sold 13,827 shares for $4.55 each. As a result, the insider received 62,860 and left with 160,437 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCAT now has a Market Capitalization of 256970800 and an Enterprise Value of 267235984. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.84 while its Price-to-Book (P/B) ratio in mrq is 0.64. Its current Enterprise Value per Revenue stands at 0.872 whereas that against EBITDA is -10.536.
Stock Price History:
The Beta on a monthly basis for HCAT is 1.59, which has changed by -0.39303482 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, HCAT has reached a high of $9.24, while it has fallen to a 52-week low of $3.56. The 50-Day Moving Average of the stock is -18.51%, while the 200-Day Moving Average is calculated to be -44.97%.
Shares Statistics:
For the past three months, HCAT has traded an average of 766.80K shares per day and 557100 over the past ten days. A total of 70.21M shares are outstanding, with a floating share count of 66.95M. Insiders hold about 4.64% of the company’s shares, while institutions hold 78.10% stake in the company. Shares short for HCAT as of 1743379200 were 3115783 with a Short Ratio of 4.06, compared to 1740700800 on 2365886. Therefore, it implies a Short% of Shares Outstanding of 3115783 and a Short% of Float of 4.5100003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
